The launch of BrightMeds GLP-1 marks a significant shift in how physicians manage diabetes mellitus . This novel medication class delivers a unique mechanism of action that not only reduces sugar but can facilitate weight loss and enhance cardiovascular health . Early findings suggest this therapy is a powerful resource for patients desiring better